Article info

PDF
Research paper
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis
  1. Correspondence to Dr M H Soilu-Hänninen, University Hospital of Turku, Department of Neurology, Kiinamyllynkatu 4-8, Turku FIN-20520, Finland; mersoi{at}utu.fi
View Full Text

Citation

Soilu-Hänninen M, Åivo J, Lindström B, et al
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

Publication history

  • Received 24 November 2011
  • Revised 28 January 2012
  • Accepted 30 January 2012
  • Published in print 1 May 2012.
  • Published online 3 April 2012.
  • Published first 22 February 2012.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.